semaglutide ileus law office in louisiana gi obstruction dallas gastric intestinal attorney semaglutide gastric intestinal obstruction lawyer in dallas GLP-1 Multi-District Litigation-150cent Rybelsus Lawsuit Lawyer semaglutide bowel obstruction law firm

Did you know that in the last few years, prescriptions for GLP-1 medications have jumped by more than 600%, yet only about 12% of Americans have access to them for weight loss or diabetes

Rounding into 2023, it was increasingly clear that GLP-1s were not only highly effective medications, but highly charismatic products with broad consumer appeal

The regulator issued a complete response letter (CRL) to Intarcia in 2017, taking issue with the stability of drug release from the device and raising concerns about cases of acute kidney injury seen in clinical trials

Cardiovascular health represents one of the most studied areas